Prasugrel and cancer: an uncertain association or a credible risk that meaningfully alters the benefit-risk balance

Arch Intern Med. 2010 Jun 28;170(12):1010-2. doi: 10.1001/archinternmed.2010.139.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / surgery
  • Angioplasty, Balloon, Coronary
  • Animals
  • Colorectal Neoplasms / chemically induced*
  • Colorectal Neoplasms / epidemiology
  • Humans
  • Incidence
  • Lung Neoplasms / chemically induced*
  • Lung Neoplasms / epidemiology
  • Mice
  • Myocardial Infarction / prevention & control
  • Neoplasms, Experimental / chemically induced
  • Neoplasms, Experimental / epidemiology
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Prasugrel Hydrochloride
  • Preoperative Care
  • Purinergic P2 Receptor Antagonists
  • Risk Factors
  • Stroke / prevention & control
  • Thiophenes / adverse effects*
  • Thiophenes / therapeutic use
  • United States / epidemiology

Substances

  • Piperazines
  • Purinergic P2 Receptor Antagonists
  • Thiophenes
  • Prasugrel Hydrochloride